Hantz Financial Services, Inc. Novartis Ag Transaction History

Hantz Financial Services, Inc.

$5.63 Billion
Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 16,234 shares of NVS stock, worth $1.69 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,234

Previous 15,986 1.55%

Holding current value

$1.69 Million

Previous $1.7 Million 9.69%

% of portfolio

0.03%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $26,320 - $29,980	248 Added 1.55%	16,234 $1.87 Million
Q2 2024 Jul 30, 2024	BUY	$92.57 - $107.37 $1.48 Million - $1.72 Million	15,986 New	15,986 $1.7 Million
Q1 2024 Aug 06, 2024	SELL	$95.27 - $108.47 $37,345 - $42,520	-392 Reduced 1.58%	24,387 $2.36 Million
Q4 2023 Aug 06, 2024	SELL	$92.27 - $101.54 $120,227 - $132,306	-1,303 Reduced 5.0%	24,779 $2.5 Million
Q3 2023 Aug 06, 2024	SELL	$94.73 - $105.13 $424,579 - $471,192	-4,482 Reduced 14.66%	26,082 $2.66 Million
Q2 2023 Aug 06, 2024	BUY	$92.52 - $104.91 $112,689 - $127,780	1,218 Added 4.15%	30,564 $3.08 Million
Q1 2023 Aug 06, 2024	BUY	$80.03 - $92.81 $8,963 - $10,394	112 Added 0.38%	29,346 $2.7 Million
Q4 2022 Aug 06, 2024	SELL	$75.55 - $92.52 $144,527 - $176,990	-1,913 Reduced 6.14%	29,234 $2.65 Million
Q3 2022 Aug 06, 2024	BUY	$74.61 - $87.26 $62,448 - $73,036	837 Added 2.76%	31,147 $2.37 Million
Q2 2022 Aug 06, 2024	BUY	$80.52 - $93.75 $124,564 - $145,031	1,547 Added 5.38%	30,310 $2.56 Million
Q1 2022 Aug 06, 2024	BUY	$80.11 - $90.62 $281,266 - $318,166	3,511 Added 13.9%	28,763 $2.52 Million
Q4 2021 Aug 06, 2024	BUY	$79.7 - $88.13 $390,370 - $431,660	4,898 Added 24.06%	25,252 $2.21 Million
Q3 2021 Aug 06, 2024	BUY	$81.78 - $95.14 $301,849 - $351,161	3,691 Added 22.15%	20,354 $1.67 Million
Q2 2021 Aug 06, 2024	BUY	$85.24 - $94.15 $354,768 - $391,852	4,162 Added 33.29%	16,663 $1.52 Million
Q1 2021 Aug 06, 2024	SELL	$83.5 - $98.47 $290,997 - $343,167	-3,485 Reduced 21.8%	12,501 $1.07 Million
Q4 2020 Aug 06, 2024	SELL	$78.07 - $94.43 $164,571 - $199,058	-2,108 Reduced 61.39%	1,326 $125,000
Q3 2020 Aug 06, 2024	BUY	$82.14 - $91.0 $10,513 - $11,648	128 Added 3.87%	3,434 $299,000
Q2 2020 Aug 06, 2024	BUY	$80.93 - $91.1 $63,125 - $71,058	780 Added 30.88%	3,306 $289,000
Q1 2020 Aug 06, 2024	SELL	$70.67 - $99.01 $951,218 - $1.33 Million	-13,460 Reduced 84.2%	2,526 $208,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Novartis Ag Transaction History